A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.
From Tom Holland and Zendaya to Taylor Swift and Travis Kelce, astrologer Aliza Kelly breaks down the compatibility of some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback